Subsequently, platelets bind to the tumor cells via I/R-induced activation of integrin (GPIIb/IIIa) and P-selectin on platelets, thus leading to the formation of platelet–tumor cells aggregates. This evidence concerns the gene ITGA2B and neoplasm.